Login / Signup

Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model.

Elías MarlinMiguel ValenciaNuria PeregrínRoberto FerreroMaría Jesús NicolásRodrigo Vinueza-GavilanesAntonio Pineda-LucenaJulio ArtiedaMontserrat ArrasateTomás Aragón
Published in: British journal of pharmacology (2023)
mice. This study reveals that the ISR works as a neuroprotective pathway in ALS motor neurons and reveals the toxicity that eIF2B activators may display in ALS patients.
Keyphrases
  • amyotrophic lateral sclerosis
  • mouse model
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • spinal cord
  • peritoneal dialysis
  • oxidative stress
  • type diabetes
  • skeletal muscle